In recent years, several new genetic risk factors of rheumatoid arthritis (RA) have been identified. The majority of genetic risk factors identified to date in connection with the auto-antibody positive RA, which about two thirds of patients with RA, but the distinction between this alternative, self-antibody-negative RA, the less destructive, more and more important. A [...]
|
||||||
|
Psoriatic arthritis affects about 11% of patients with psoriasis. Anti-tumor necrosis factor α (anti-TNFα) active substances, blocks signal molecules that induce inflammation, the symptoms of psoriatic arthritis. Golimumab is a human monoclonal antibody against the TNFα and was positive within two weeks after the first subcutaneous injection of a phase II study of rheumatoid arthritis. [...] Racial differences in health care occur, even for the insured population with access to health care. This leads to the conclusion that some of the differences in health care, using different ethnic groups because of patient preferences. Rheumatoid arthritis (RA) management decisions are often complex, several Trade-offs between the relief of symptoms long-term reduction of [...] Use of certain drugs known as monoclonal antibodies anti-tumor necrosis factor α (TNF-α) antibody for the treatment of rheumatoid arthritis appears to be at increased risk for herpes zoster (shingles), the painful infection bubbles, following a new study. Young and middle-aged adults rather to interpret the chronic shoulder pain as a result of sports and overuse injuries and shrugs. But some of the patients under 50 years can not just raise your shoulders in addition to pain, because it’s too bad. |
||||||
|
Copyright © 2010 MICKL - All Rights Reserved |
||||||
Recent Comments